A 2006 40under40 winner, Dr Stewart Washer has over 20 years of CEO and board experience, founding several biotechnology companies in both the agri-food and medical sectors. He is chair of Orthocell which cultures tendon cells to repair damaged tendons, chair of Cynata Therapeutics which develops stem cell therapies, and chair of Minomic International which has an accurate non-invasive test for prostate cancer. Dr Washer was the chief executive of Calzada, founding chief executive of Phylogica, chief executive of Celentis, and managed the commercialisation of intellectual property from AgResearch in New Zealand with 650 Scientists and $130m revenues. He was also a founder of a NZ$120m New Zealand-based life science fund and venture partner with Swiss-based Inventages Nestlé Fund. Dr Washer held a number of board positions including as chair of iSonea, Resonance Health, and Hatchtech; and director of iCeutica, Immuron and AusBiotech. He was also a senator with Murdoch University. In March 2005, Dr Washer took biotechnology company Phylogica through a successful and oversubscribed initial public offering to list on the ASX at a 30 per cent premium. Phylogica had a novel drug discovery technology based on parts of proteins derived from diverse micro-organisms that are being developed to treat stroke, diabetes, asthma and other inflammatory diseases.
Bio last updated 30 Nov 2019
BNiQ Network Graph
Displaying all related organisations and their related contacts. Hover over a node to display a link to the BNiQ page for that person or organisation.
Access to our data for Stewart Washer is only available to paid subscribers with BNiQ access.
The BNiQ search engine is Western Australia's most accurate and comprehensive business listings and searchable database.
Stewart Washer is linked to 12 organisations which are included in 1 list - Public Companies - Industrial.
To see the data you will need to subscribe.
Total Shareholder Return as at 30/04/20
All 40under40 winners for 2006